Neuren Pharmaceuticals Limited · ASX:NEU
Neuren Pharmaceuticals — Shareholder Meeting (May 2005)
17 slides from Neuren Pharmaceuticals's shareholder meeting presentation, May 30, 2005
Slide 1: Neuren Pharmaceuticals AGM cover letter
Neuren Pharmaceuticals Ltd Level 3, 2-6 Park Avenue, Grafton Nl e U Te | | Auckland, New Zealand office: +64 9 367 7167 fax: +64 9 367 7186 [email protected] pharma ceuti cals www.neurenpharma.com 30 May 2005 The Company Announcements Office Australian Stock Exchange Limited BY E-LODGEMENT De
Slide 2: Neuren
neuren
Slide 3: Partnerships and board and management strengthening
aan Ee ene A oN ERNE RNIM + Partnership ~« US Army ~ + Metabolic - Board and Management Strengthens neuren x _ — oa
Slide 4: nim
ae i 7 vn nim zy IN iii i nnn 2) i) i i il #2) a a eed
Slide 5: Metabolic Syndrome / Breast Cancer
Metabolic Syndrome Breast Cancer neuren
Slide 6: NNZ-2566 (oral)
* NNZ-2566 (oral) cme iy - DKP’s +MC’s *NRP’s + GH Cancer + GH Variants neuren
Slide 7: i ala
an i ala i} | niversity of Hou <<. os ng Potentia neuren
Slide 8: Phase on target, manufacturing finalised
LN ce au ot Wunte nn LNAI nn a na ii - Phase 1 on target . - Manufacturing Finalised and Cost Effec - Tox Study Supplier Selected neuren : _—rrrr—_—Cii_COC
Slide 9: Brain injury drug with US arm
a LL. pi iin on AM i) MM) J i i «Additional work with US arm e / 8 7 « “Goal... advanced drug for brain inju y”
Slide 10: Government grant and MBP peptide chemistry
nent iH ao NAM i Mi Ni fD — i a dependent v. * Government Grant AS585 e Utilise MBP Peptide Chemistry S neuren ie
Slide 11: TTT TTC Te
TTT TTC Te a lt TG I ee CCl a i lil neuren “ Lees a ag Se
Slide 12: Clinical Development Experience
Slinical Development Experience ¢ Rob Turnbull, | private B P a * Prof. Stan Newman neuren “a — oo
Slide 13: fy ai
fy ai Wh a BA Ss i elie 7 Raum a enor positior ions in healthcar ), Sout esi i Ih ae neuren — ae .
Slide 14: nnn eae
nnn eae i) i) SM itn iM neuren : | ~
Slide 15: wan
wan neuren < — a
Slide 16: Robust and focused drug development
RNG Oe BI) - INC includ the pi ther science — Robust and focused drug development neuren oo a .
Slide 17: Neuren
neuren SE neuren : ee eo a:
Neuren Pharmaceuticals — Shareholder Meeting (May 2005) on 6ix